[Anesthesia with Neuromuscular Diseases]

Overview

Journal Anaesthesist

Specialty Anesthesiology

Date 2010 Oct 6

PMID 20922354

Citations 2

Authors

M U Gerbershagen

F Wappler

Affiliations

Soon will be listed here.

Abstract

Among the neuromuscular diseases (NMDs) over 800 individual entities have been identified. The vast majority of these diseases occur very seldom but all NMDs together add up to a prevalence of 1:1,500. Accordingly the conclusion "seldom diseases are common" seems to be appropriate. The scope of NMDs is very wide varying from the affection of single muscle groups to the complete musculature, from slowly progressive to fulminant progressive forms, from perinatal to the adult manifestation as well as number, course and character of associated comorbidities. Due to the wide heterogeneity concerning NMDs it is of great importance for anesthesiologists to be knowledgeable on relevant comorbidities as well as indications and contraindications for the various anesthetics.

Citing Articles

Regional anesthesia as a safe option in patient with limb girdle muscular dystrophy undergoing total abdominal hysterectomy: A case report and case review.

Devkota S, Shrestha S, Gurung T, Shrestha S Clin Case Rep. 2022; 10(11):e6523.

PMID: 36381058 PMC: 9637942. DOI: 10.1002/ccr3.6523.

Anesthetic management of a patient with limb-girdle muscular dystrophy 2B:CARE-compliant case report and literature review.

Cao X, Joypaul K, Cao F, Gui L, Hu J, Mei W BMC Anesthesiol. 2019; 19(1):155.

PMID: 31421689 PMC: 6698341. DOI: 10.1186/s12871-019-0813-8.

References

Hsu D . Cardiac manifestations of neuromuscular disorders in children. Paediatr Respir Rev. 2010; 11(1):35-8. DOI: 10.1016/j.prrv.2009.10.004. View

Benca J, Hogan K . Malignant hyperthermia, coexisting disorders, and enzymopathies: risks and management options. Anesth Analg. 2009; 109(4):1049-53. DOI: 10.1213/ane.0b013e3181adca28. View

Hebl J, Kopp S, Schroeder D, Horlocker T . Neurologic complications after neuraxial anesthesia or analgesia in patients with preexisting peripheral sensorimotor neuropathy or diabetic polyneuropathy. Anesth Analg. 2006; 103(5):1294-9. DOI: 10.1213/01.ane.0000243384.75713.df. View

Poole T, Lim T, Buck J, Kong A . Perioperative cardiac arrest in a patient with previously undiagnosed Becker's muscular dystrophy after isoflurane anaesthesia for elective surgery. Br J Anaesth. 2010; 104(4):487-9. DOI: 10.1093/bja/aeq035. View

Hayes J, Veyckemans F, Bissonnette B . Duchenne muscular dystrophy: an old anesthesia problem revisited. Paediatr Anaesth. 2008; 18(2):100-6. DOI: 10.1111/j.1460-9592.2007.02302.x. View

Smelt W . Cardiac arrest during desflurane anaesthesia in a patient with Duchenne's muscular dystrophy. Acta Anaesthesiol Scand. 2005; 49(2):267-9. DOI: 10.1111/j.1399-6576.2004.00596.x. View

Klingler W, Rueffert H, Lehmann-Horn F, Girard T, Hopkins P . Core myopathies and risk of malignant hyperthermia. Anesth Analg. 2009; 109(4):1167-73. DOI: 10.1213/ANE.0b013e3181b5ae2d. View

Schutte J, Gerbershagen M, Wappler F . [Anaesthesia associated rhabdomyolysis. Diagnosis, therapy and prevention of skeletal muscle breakdown]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2006; 41(7-8):454-61. DOI: 10.1055/s-2006-949505. View

Beloiartsev A, Gableske S, Hubler M . [Neuromuscular monitoring in patients with neuromuscular diseases. Options and needs]. Anaesthesist. 2009; 58(7):731-41. DOI: 10.1007/s00101-009-1578-0. View

10.

Parness J, Bandschapp O, Girard T . The myotonias and susceptibility to malignant hyperthermia. Anesth Analg. 2009; 109(4):1054-64. DOI: 10.1213/ane.0b013e3181a7c8e5. View

11.

Unterbuchner C, Fink H, Blobner M . The use of sugammadex in a patient with myasthenia gravis. Anaesthesia. 2010; 65(3):302-5. DOI: 10.1111/j.1365-2044.2009.06236.x. View

12.

Finucane B, Terblanche O . Prolonged duration of anesthesia in a patient with multiple sclerosis following paravertebral block. Can J Anaesth. 2005; 52(5):493-7. DOI: 10.1007/BF03016529. View

13.

Schmitt H, Munster T, Heuss D . Anesthesia in Friedreich's ataxia. Paediatr Anaesth. 2005; 15(11):1023-4. DOI: 10.1111/j.1460-9592.2005.01725.x. View

14.

Wiertlewski S, Magot A, Drapier S, Malinovsky J, Pereon Y . Worsening of neurologic symptoms after epidural anesthesia for labor in a Guillain-Barré patient. Anesth Analg. 2004; 98(3):825-7, table of contents. DOI: 10.1213/01.ane.0000101985.38587.1b. View

15.

Levitan R . Safety of succinylcholine in myasthenia gravis. Ann Emerg Med. 2005; 45(2):225-6. DOI: 10.1016/j.annemergmed.2004.08.045. View

16.

Allen J . Pulmonary complications of neuromuscular disease: a respiratory mechanics perspective. Paediatr Respir Rev. 2010; 11(1):18-23. DOI: 10.1016/j.prrv.2009.10.002. View

17.

Wick S, Muenster T, Schmidt J, Forst J, Schmitt H . Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy. Anesthesiology. 2005; 102(5):915-9. DOI: 10.1097/00000542-200505000-00009. View

18.

Roussos C, Macklem P . The respiratory muscles. N Engl J Med. 1982; 307(13):786-97. DOI: 10.1056/NEJM198209233071304. View

19.

Farag E, Deboer G, Cohen B, Niezgoda J . Metabolic acidosis due to propofol infusion. Anesthesiology. 2005; 102(3):697-8. DOI: 10.1097/00000542-200503000-00042. View

20.

Moller Petrun A, Mekis D, Kamenik M . Successful use of rocuronium and sugammadex in a patient with myasthenia. Eur J Anaesthesiol. 2010; 27(10):917-8. DOI: 10.1097/EJA.0b013e3283392593. View